In an ovarian cancer cell model, Yang et al. [40] demonstrated that inhibiting FASN leads to the transcriptional upregulation of REDD1, mediated by the ER stress transcription factor ATF4, which prevents de novo FA synthesis and ultimately reduces tumor cell survival. The gene discussed is FASN; the disease is neoplasm.